These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33015829)

  • 21. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
    Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
    Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma.
    Yu M; Yang H; Wu K; Ji Y; Ju L; Lu X
    Bioorg Med Chem; 2014 Aug; 22(15):4109-18. PubMed ID: 24934992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX-2 Inhibitors.
    Ahmaditaba MA; Shahosseini S; Daraei B; Zarghi A; Houshdar Tehrani MH
    Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28872704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
    Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W
    Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation.
    Yan XQ; Wang ZC; Zhang B; Qi PF; Li GG; Zhu HL
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31052167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
    Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives.
    Abdel-Sayed MA; Bayomi SM; El-Sherbeny MA; Abdel-Aziz NI; ElTahir KE; Shehatou GS; Abdel-Aziz AA
    Bioorg Med Chem; 2016 May; 24(9):2032-42. PubMed ID: 27025563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
    Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
    Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis and Biological Activities of New Pyrazole Derivatives Possessing Both Coxib and Combretastatins Pharmacophores.
    Thi THN; Thi YT; Nguyen LA; Vo NB; Ngo QA
    Chem Biodivers; 2019 Jun; 16(6):e1900108. PubMed ID: 30977306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors.
    Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developments in synthesis of the anti-inflammatory drug, celecoxib: a review.
    Kumar V; Kaur K; Gupta GK; Gupta AK; Kumar S
    Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):124-34. PubMed ID: 23565678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.
    Bennani FE; Doudach L; Cherrah Y; Ramli Y; Karrouchi K; Ansar M; Faouzi MEA
    Bioorg Chem; 2020 Apr; 97():103470. PubMed ID: 32120072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking.
    El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Asiri YA; Abdel-Aziz AA
    Eur J Med Chem; 2018 Oct; 158():134-143. PubMed ID: 30216848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
    Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
    Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
    Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II.
    Song Y; Feng S; Feng J; Dong J; Yang K; Liu Z; Qiao X
    Eur J Med Chem; 2020 Aug; 200():112459. PubMed ID: 32502865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.